Back to results
US 2023/0404950 A1Published application
Sodium oxybate to treat idiopathic hypersomnia
AssigneeJazz Pharmaceuticals Ireland Limited
InventorsFranck SKOBIERANDA, Dan CHEN, Amanda Leigh STERKEL
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably sodium oxybate.
Claims54
A method of treating idiopathic hypersomnia in a patient in need thereof, the method comprising:
- administering a therapeutically effective amount of sodium oxybate to the patient.
A method of treating idiopathic hypersomnia in a patient in need thereof, the method comprising:
- administering a therapeutically effective amount of sodium oxybate to the patient, wherein the sodium oxybate is administered as a liquid and the concentration of sodium oxybate in the liquid is about 500 mg/mL.
Dependencies are inferred from the claim text.